Evidence map›Paper›PMID 40767373›Full record

ArticleAmerican journal of medical genetics. Part A2025

Exonic Variation and Its Clinical Impact in 7221 Old Order Amish.

Braxton D Mitchell, Ebuka Onyenobi, Joshua P Lewis, Brady Gaynor, James A Perry, Kristin Maloney, Jeffrey R O'Connell, Jessica Tiner, Amber L Beitelshees, Cristopher V Van Hout and 12 more

Abstract read
In one paragraph

Article in American journal of medical genetics. Part A, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Braxton D MitchellDepartment of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA.ORCID 0000-0003-4920-4744
Ebuka OnyenobiDepartment of Epidemiology & Public Health, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Joshua P LewisDepartment of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Brady GaynorDepartment of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA.
James A PerryDepartment of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Kristin MaloneyDepartment of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Jeffrey R O'ConnellDepartment of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Jessica TinerDepartment of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Amber L BeitelsheesDepartment of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Cristopher V Van HoutLaboratorio Internacional de Investigatión Sobre el Genoma Humano, Universidad Nacional Autónoma de México Campus Juriquilla, Querétaro, Mexico.
Patrick F McArdleDepartment of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Huichun XuDepartment of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Erik G PuffenbergerClinic for Special Children, Gordonville, Pennsylvania, USA.ORCID 0000-0002-6388-9148
Karlla W BrigattiClinic for Special Children, Gordonville, Pennsylvania, USA.
Melanie DaueDepartment of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Hilary B WhitlatchDepartment of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Anna AlkelaiRegeneron Genetics Center LLC, Tarrytown, New York, USA.
Alejandro A SchäfferCancer Data Science Laboratory, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
John OvertonRegeneron Genetics Center LLC, Tarrytown, New York, USA.
Elizabeth A StreetenDepartment of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Toni I PollinDepartment of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Alan R ShuldinerDepartment of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA.

Funding

Genome-wide Search for CVD Gene-Environment InteractionsU01HL072515 · NHLBI · UNIVERSITY OF MARYLAND BALTIMORE · PI SHULDINER, ALAN R. · 2002 to 2008
$11.2M
RESEARCH TRAINING IN THE EPIDEMIOLOGY OF AGINGT32AG000262 · NIA · UNIVERSITY OF MARYLAND BALTIMORE · PI ANN L GRUBER-BALDINI, DENISE L ORWIG · 1998 to 2026
$8.2M
Pharmacogenomics of CVD risk ReductionU01GM074518 · NIGMS · UNIVERSITY OF MARYLAND BALTIMORE · PI SHULDINER, ALAN R. · 2005 to 2009
$7.3M
GENETICS OF DIABETES IN THE AMISHR01DK054261 · NIDDK · UNIVERSITY OF MARYLAND BALTIMORE · PI SHULDINER, ALAN R. · 2000 to 2009
$5.1M
Longevity Genes in Founder PopulationsR01AG018728 · NIA · UNIVERSITY OF MARYLAND BALTIMORE · PI SHULDINER, ALAN R. · 2001 to 2005
$3.8M
Genetic Influences on Coronary Artery CalcificationR01HL088119 · NHLBI · UNIVERSITY OF MARYLAND BALTIMORE · PI MITCHELL, BRAXTON D · 2007 to 2010
$2.8M
GENETICS OF OSTEOPOROSIS IN THE AMISHR01AR046838 · NIAMS · UNIVERSITY OF MARYLAND BALTIMORE · PI SHULDINER, ALAN R. · 2000 to 2004
$2.7M
Joint Determinants of Bone Density and CVD CalcificationR01HL069313 · NHLBI · UNIVERSITY OF MARYLAND BALTIMORE · PI MITCHELL, BRAXTON D · 2001 to 2004
$1.4M
Intramural Research, National Institute of Health, National Cancer InstituteNHLBI NIH HHS R01 HL069313NHLBI NIH HHS R01 HL088119NHLBI NIH HHS U01 HL072515NIAMS NIH HHS R01 AR046838NIA NIH HHS R01 AG018728NIA NIH HHS T32 AG000262NIDDK NIH HHS R01 DK054261NIGMS NIH HHS U01 GM074518NIH HHS P30 AG000262NIH HHS R01 AG18728NIH HHS R01 AR46838NIH HHS R01 DK54261NIH HHS R01 HL088119NIH HHS R01 HL69313NIH HHS U01 GM074518NIH HHS U01 HL072515Regeneron Genetics Center
6 · The paper itself

Abstract

The Amish of Lancaster County, PA has been the focus of genetic studies for many years due to its demographic history and unique genetic makeup that includes a historical bottleneck event and subsequent genetic drift, resulting in a marked decrease in genetic diversity and increased frequency of some variants that have substantially shaped the health of the community. To characterize the coding variation in the Amish genome, we sequenced the exomes of 7221 adult community members, and in this report, we contrast genetic diversity between the Amish and Europeans from the UK Biobank. Exome sequences of 7221 Amish contained only 14% as many variants as the same number of UKB participants. This reduced genetic diversity has substantial clinical implications. We identified pathogenic (P) and likely pathogenic (LP) variants from ClinVar and a population-specific genetic screening panel and found that most of the variants present in the Amish were highly enriched, resulting in 5.2% of Amish individuals being homozygous for a recessive P/LP variant and 25.6% being heterozygous for at least one dominant P/LP variant. In 43.6% of the 2141 Amish spouse-pairs in our sample, at least one spouse was heterozygous for a P/LP dominant variant, and 24.3% of couples were autosomal recessive disease carrier couples, meaning that each of their children was at ~25% risk of inheriting two copies of that variant. Gene discovery efforts in other founder communities will likely uncover distinct P (and beneficial) variants impacting the health of these communities, with implications for all of human health.

Indexed as

AmishExonsGenetic VariationAdultExomeExome SequencingFemaleGenetic Predisposition to DiseaseGenetic TestingGenome, HumanHeterozygoteHumansMaleMiddle AgedWhite PeopleAmishexomesfounder populationpathogenic variantspopulation genetics

Identifiers

PMID40767373
PMCPMC13386165

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.